Morgan Stanley
DH icon

Morgan Stanley’s Definitive Healthcare DH Stock Holding History

Morgan Stanley’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Sell
254,149
-170,152
-40% -$156K ﹤0.01% 5934
2026
Q1 		$522K Sell
424,301
-699,345
-62% -$1.22M ﹤0.01% 5463
2025
Q4 		$3.22M Sell
1,123,646
-276,148
-20% -$766K ﹤0.01% 4488
2025
Q3 		$5.68M Sell
1,399,794
-152,391
-10% -$608K ﹤0.01% 4043
2025
Q2 		$6.05M Buy
1,552,185
+229,668
+17% +$724K ﹤0.01% 3896
2025
Q1 		$3.82M Buy
1,322,517
+546,954
+71% +$2.22M ﹤0.01% 4153
2024
Q4 		$3.19M Buy
775,563
+34,391
+5% +$150K ﹤0.01% 4351
2024
Q3 		$3.31M Buy
741,172
+311,269
+72% +$1.46M ﹤0.01% 4286
2024
Q2 		$2.35M Sell
429,903
-175,125
-29% -$1.1M ﹤0.01% 4454
2024
Q1 		$4.88M Buy
605,028
+104,653
+21% +$926K ﹤0.01% 3927
2023
Q4 		$4.97M Sell
500,375
-48,647
-9% -$382K ﹤0.01% 3923
2023
Q3 		$4.39M Buy
549,022
+150,402
+38% +$1.51M ﹤0.01% 3853
2023
Q2 		$4.38M Sell
398,620
-150,311
-27% -$1.55M ﹤0.01% 3875
2023
Q1 		$5.67M Buy
548,931
+198,054
+56% +$2.33M ﹤0.01% 3674
2022
Q4 		$3.86M Sell
350,877
-20,727
-6% -$266K ﹤0.01% 3974
2022
Q3 		$5.77M Buy
371,604
+55,426
+18% +$1.22M ﹤0.01% 3553
2022
Q2 		$7.25M Sell
316,178
-49,337
-13% -$1.06M ﹤0.01% 3410
2022
Q1 		$9.01M Buy
365,515
+322,970
+759% +$7.29M ﹤0.01% 3024
2021
Q4 		$1.16M Buy
42,545
+39,225
+1,181% +$1.37M ﹤0.01% 4962
2021
Q3 		$142K Buy
+3,320
New +$147K ﹤0.01% 6181

Other funds holding DH

AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Morgan Stanley's DH Position: Q2 2026 in Review

Morgan Stanley reduced its Definitive Healthcare (DH) stake by 40% in Q2 2026, selling an estimated $156K and leaving 254,149 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #5934.

Morgan Stanley first reported a position in DH in Q3 2021 and has held it in 20 quarters since. The position peaked at $9.01M in Q1 2022. 99 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • Morgan Stanley held 254,149 shares of Definitive Healthcare worth $211K as of Q2 2026.
  • Morgan Stanley sold 170,152 Definitive Healthcare shares in Q2 2026, an estimated $156K.
  • Definitive Healthcare made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5934 holding.
  • Morgan Stanley first reported a position in Definitive Healthcare in Q3 2021 and has held it in 20 quarters since.
  • Morgan Stanley's Definitive Healthcare position peaked at $9.01M in Q1 2022.
  • 99 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.